Evidence map›Paper›PMID 41688935›Full record

ArticleBMC ophthalmology2026

Corneal morphological changes after discontinuation of long-term orthokeratology and SMILE surgery outcomes: a retrospective comparative study.

Kun Zhou, Xiaohuan Ma, Di Shen, Wenjia Cao, Xiyu Sun, Mengchen Li, Wei Wei

Abstract readComparative Study
In one paragraph

Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kun ZhouDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Xiaohuan MaDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Di ShenDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Wenjia CaoDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Xiyu SunDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Mengchen LiDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China.
Wei WeiDepartment of Ophthalmology, Xi'an No.1 Hospital, 30 Fenxiang, The South Avenue, Xi'an, Shaanxi Province, 710002, China. wills2015@foxmail.com.

Funding

2024 Xi'an Science and Technology Program Project 1: 24YXYJ0047 (Project Title: "Clinical Study on the Prevention and Control of Myopia Onset and Progression in Adolescents Using Peripheral Defocus Spectacle Lenses and 0.01% Atropine Eye Gel")
6 · The paper itself

Abstract

backgroundOrthokeratology (OK) has been widely adopted as a non-surgical intervention to slow myopia progression in children and adolescents. In China, where myopia prevalence is exceptionally high, OK lenses are commonly prescribed to school-aged children as an early intervention strategy. As these individuals reach adulthood, many pursue permanent refractive correction-such as small-incision lenticule extraction (SMILE)-to meet unaided visual acuity standards required for university entrance, military service, or certain occupations. However, the long-term morphological effects of OK wear and their potential impact on SMILE outcomes remain inadequately understood. This study aimed to evaluate ocular biometric and corneal morphological changes following long-term OK lens discontinuation and to compare the visual and surgical outcomes of SMILE between former OK users and spectacle-wearing controls.

methodsThis retrospective comparative study included 44 myopic eyes-22 from patients with a history of OK lens wear (average duration: 64.8 ± 22.6 months; discontinuation ≥ 3 months) and 22 from age- and refractive error-matched controls. Examinations were conducted pre-OK (baseline), pre-SMILE, and at 1 month, 6 months, and final follow-up. Parameters included uncorrected and corrected distance visual acuity (UDVA, CDVA), corneal topography, pachymetry, volume, curvature, and higher-order aberrations. Astigmatic outcomes were evaluated using Alpins vector analysis.

resultsAfter OK discontinuation, the OK group exhibited increased corneal astigmatism (P = 0.030), spherical aberration (P = 0.036), and total aberrations (P = 0.034), as well as decreased vertical coma (P = 0.004), central corneal thickness (P < 0.001), and corneal volume (P = 0.001). Posterior corneal curvature steepened significantly (P < 0.001), while anterior curvature remained stable. Further correlation analysis showed that a younger age at initial OK lens wear was significantly associated with greater posterior steepening after discontinuation at the 3 mm, 5 mm, and 7 mm zones (all P < 0.050). There was also a borderline negative correlation between the duration of OK lens wear and changes in posterior steep K value, suggesting longer wear may result in more pronounced steepening. At 6 months and final follow-up, both groups demonstrated comparable UDVA, CDVA, corneal shape, and higher-order aberrations (all P > 0.050). Vector analysis revealed no significant group differences in astigmatic correction.

conclusionsSMILE remains a viable option for former OK users; the observed reduction in CCT after lens discontinuation has minimal impact on refractive surgery selection.

Indexed as

CorneaCorneal Surgery, LaserMyopiaOrthokeratologic ProceduresRefraction, OcularAdolescentAdultChildCorneal TopographyFemaleFollow-Up StudiesHumansMaleRetrospective StudiesTreatment OutcomeVisual AcuityKeratometryOcular biometryOrthokeratologySMILE refractive surgery

Identifiers

PMID41688935
PMCPMC13005484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.